Components of Sarcopenia and Frailty in Relation to Cognitive Impairment in Older Adults: An Ambispective Cohort Study from a Tertiary Hospital
Keywords:
sarcopenia, frailty, mild cognitive impairment, rapid cognitive screeningAbstract
Background: Sarcopenia and frailty are common geriatric syndromes that may contribute to mild cognitive impairment (MCI). Evidence regarding the independent roles of individual sarcopenia components and frailty in MCI remains limited in low- and middle-income countries. This study evaluated the association between sarcopenia components, frailty, and MCI among older adults in Indonesia. Methods: An ambispective cohort study was conducted among adults aged ≥60 years attending the Geriatric Outpatient Clinic of Dr. Cipto Mangunkusumo National General Hospital, Jakarta. Sarcopenia components were assessed using SARC-Calf (low muscle mass indicator), handgrip strength, and the five-times sit-to-stand test. Frailty was evaluated using the FRAIL scale. Cognitive function was assessed using the Rapid Cognitive Screening. Multivariate log-binomial or Poisson regression with robust variance was used to estimate adjusted risk ratios (RRs) for MCI. Results: A total of 121 participants (median age 74 years; 68.6% female) were included, with an MCI prevalence of 21.5%. After adjustment for confounders, low muscle mass indicator (RR 2.206; 95% CI 1.045–4.652) and low muscle strength (RR 3.006; 95% CI 1.202–7.517) were independently associated with MCI. Low physical performance (RR 1.773; 95% CI 0.796–3.773) and frailty (RR 1.086; 95% CI 0.377–3.134) were not significantly associated with MCI. Conclusion: Low muscle mass indicators and reduced muscle strength were independently associated with MCI, supporting the integration of simple sarcopenia screening tools into routine geriatric cognitive assessment.References
Walston JD. Sarcopenia in older adults. Curr Opin Rheumatol. 2012;24:623–7.
Breton A, Casey D, Arnaoutoglou NA. Cognitive tests for detecting mild cognitive impairment: meta-analysis. Int J Geriatr Psychiatry. 2019;34:233–42.
Scisciola L, Fontanella RA, Surina, Cataldo V, Paolisso G, Barbieri M. Sarcopenia and cognitive function: Role of myokines in muscle–brain cross-talk. Life. 2021;11:173.
Picca A, Coelho-Junior HJ, Calvani R, Marzetti E, Vetrano DL. Biomarkers shared by frailty and sarcopenia: systematic review and meta-analysis. Ageing Res Rev. 2022;73:101530.
Amini N, Ibn Hach M, Lapauw L, et al. Meta-analysis on the interrelationship between sarcopenia and mild cognitive impairment, Alzheimer’s disease, and dementia. J Cachexia Sarcopenia Muscle. 2024;15:1240–53.
Peng TC, Chen WL, Wu LW, Chang YW, Kao TW. Sarcopenia and cognitive impairment: systematic review and meta-analysis. Clin Nutr. 2020;39:2695–701.
Jacob L, Kostev K, Smith L, et al. Sarcopenia and mild cognitive impairment in older adults from six LMICs. J Alzheimer’s Dis. 2021;82:1745–54.
Tran J, Nimojan T, Saripella A, et al. Rapid cognitive assessment tools for screening mild cognitive impairment: systematic review. J Clin Anesth. 2022;78:110682.
Kandinata SG, Widajanti N, Ichwani J, Firdausi H, Aryana IGPS, Alkaff FF. Diagnostic performance of calf circumference, SARC-F, and SARC-CalF for sarcopenia screening in Indonesia. Sci Rep. 2023;13:9824.
Malmstrom TK, Morley JE. SARC-F: A simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14:531–2.
Mo YH, Zhong J, Dong X, et al. Comparison of three screening methods for sarcopenia in community-dwelling older adults. J Am Med Dir Assoc. 2021;22:746–750.e1.
Kunutsor SK, Isiozor NM, Voutilainen A, Laukkanen JA. Handgrip strength and risk of cognitive outcomes: new prospective study and meta-analysis of 16 observational cohort studies. Geroscience. 2022;44:2007–24.
Kim KH, Park SK, Lee DR, Lee J. The relationship between handgrip strength and cognitive function in elderly koreans over 8 years: A prospective population-based study using the Korean longitudinal study of ageing. Korean J Fam Med. 2019;40:9–15.
Wang P, Si Y, Cai Z, et al. The relationship between grip strength, 6-minute walking distance, and working memory in older adults with mild cognitive impairment: an fNIRS study. BMC Geriatr. 2025;25:437.
Tian Q, Resnick SM, Studenski SA, Ferrucci L. Lap time variability from a 400- m walk is associated with future mild cognitive impairment and alzheimer’s disease. J Am Med Dir Assoc. 2019;20:1535-1539.e3
Wallace LMK, Theou O, Godin J, Andrew MK, Bennett DA, Rockwood K. Frailty as a moderator of neuropathology–dementia associations. Lancet Neurol. 2019;18:177–84.
Yuan Y, Lapane KL, Tjia J, Baek J, Liu SH, Ulbricht CM. Physical frailty and cognitive impairment in U.S. nursing homes. Dement Geriatr Cogn Disord. 2021;50:60–7.
Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment. Neurology. 2018;90:126–35.
Antonelli Incalzi R, Cesari M, Pedone C, Carosella L, Carbonin PU. Construct validity of the Abbreviated Mental Test. Dement Geriatr Cogn Disord. 2003;15:199–206.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Jessica Marsigit, Siti Setiati, Tiara Aninditha, Ikhwan Rinaldi, Irsan Hasan, Robert Sinto, Noto Dwimartutie, R. M. Suryo Anggoro, Eric Daniel Tenda
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
